Goldman Sachs
-
Realty Income Corp, the US real estate investor, made its debut in the green bond market on Thursday with a sterling deal, with the issuer pricing its first foray into the structure inside its own curve. -
Xiaomi Corp sold an $800m 10 year bond and a $400m 30 year bond this week amid a difficult market for Chinese bonds and technology companies. But the mobile phone maker's green tranche, as well as its business model, attracted investors and allowed for tight pricing. Morgan Davis reports.
-
Sterling investors had their choice of ultra-long dated corporate bonds on Wednesday, as charitable foundation the Wellcome Trust and Flagship Housing Group printed 50 and 40 year paper, respectively.
-
A trio of green labelled debuts attracted “slim” demand on Wednesday, as the three senior deals had to compete with a flurry of other trades for a slice of the shrinking pre-summer investor pool.
-
PizzaExpress is looking to raise sterling bonds to refinance its capital structure, after bondholders took control of it last year from Chinese private equity group Hony Capital.
-
France is preparing a 30 year OAT syndication, capitalising on a market that seems eager for paper that has snapped up an EFSF tap with an order book more than eight times subscribed.
-
South Korea’s busy IPO market is continuing to pump out deals, with the latest listings coming from Kakao Pay and Covid-19 test maker SD Biosensor. But issuers still have to be realistic, as Krafton found out when it shot for, but missed, the country’s largest ever IPO.
-
-
Greece's Alpha Bank attracted healthy demand for its €800m share sale, in the latest sign of the country’s economic rehabilitation following the eurozone crisis.
-
Voltalia, a French renewable energy company, has signed a €170m sustainability-linked loan, with the deal adding to the growing trend of second party opinion providers becoming a central part of ESG finance.
-
BNP Paribas has retained its place at the top of the EMEA loan league table for the first half of 2021, but its market share is much smaller than for the same period last year.
-
Medlive Technology and Brii Biosciences are tapping investors for a combined HK$6.7bn ($863m).
